UK markets closed

Merck KGaA (0O14.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
179.74+8.94 (+5.24%)
At close: 06:45PM BST
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.69
52-week change 31.02%
S&P500 52-week change 326.49%
52-week high 3202.30
52-week low 3145.65
50-day moving average 3160.63
200-day moving average 3169.25

Share statistics

Avg vol (3-month) 3168.68k
Avg vol (10-day) 3250.6k
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8128.91M
% held by insiders 10.06%
% held by institutions 157.27%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 32.20
Trailing annual dividend yield 31.29%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 22:1
Last split date 330 Jun 2014

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.07%
Operating margin (ttm)18.18%

Management effectiveness

Return on assets (ttm)4.57%
Return on equity (ttm)10.07%

Income statement

Revenue (ttm)20.82B
Revenue per share (ttm)47.92
Quarterly revenue growth (yoy)-3.30%
Gross profit (ttm)N/A
EBITDA 5.12B
Net income avi to common (ttm)2.72B
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-12.80%

Balance sheet

Total cash (mrq)3.16B
Total cash per share (mrq)7.29
Total debt (mrq)9.95B
Total debt/equity (mrq)35.46%
Current ratio (mrq)1.29
Book value per share (mrq)64.54

Cash flow statement

Operating cash flow (ttm)3.97B
Levered free cash flow (ttm)3.16B